Humana Stock Forecast
NYSE: HUMHealthcareHealthcare PlansUSD
At close: Oct 7, 4:02 PM ET · Delayed 15 min
After hours: 396.51 +0.08%
HUM analyst consensus
Consensus (26 analysts)
buy
Avg. price target
$423.74+6.87%
- Strong buy 2
- Buy 11
- Hold 12
- Sell 1
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 26 Wall Street analysts covering Humana (2026-10-07), 13 rate the stock a buy or strong buy, 12 rate it a hold and 1 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $423.74, with a high estimate of $515.00 and a low estimate of $280.00. The average target implies upside of 6.9% from the current price of $396.51.
The spread between the highest and lowest targets is 83.9%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for HUM.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 2 | 8% |
| Buy | 11 | 42% |
| Hold | 12 | 46% |
| Sell | 1 | 4% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $280.00 | -29.38% |
| Average target | $423.74 | +6.87% |
| High target | $515.00 | +29.88% |